Synthesis and Antiproliferative Activitiy of Novel Diaryl Ureas Possessing a 4<i>H-</i>Pyrido[1,2-<i>a</i>]pyrimidin-4-one Group
Peng Yao,Xin Zhai,Dong Liu,Bao Hui Qi,Hai Liang Tan,Yong Cai Jin,Ping Gong
DOI: https://doi.org/10.1002/ardp.200900130
2010-01-01
Archiv der Pharmazie
Abstract:We herein disclose a series of novel diaiyl urea derivatives possessing a 4H-pyrido[1,2-a]pyrimidin-4-one group as novel potent anticancer compounds. The structures were confirmed by IR, H-1-NMR, and MS. All the compounds were screened for their antiprofilerative activity agaist the human breast cancer cell line (MDA-MB-231). The pharmacological results indicated that most of the compounds showed moderate activity. The best of this series is compound 4c (IC50 = 0.7 mu mol/L), with a potency 3.6-fold higher than Sorafenib (IC50 = 2.5 mu mol/L), which was approved in 2005.